###begin article-title 0
Modulation of experimental autoimmune encephalomyelitis by endogenous Annexin A1
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
Autoimmune diseases, like multiple sclerosis, are triggered by uncontrolled activation of cells of the immune system against self-antigen present, for instance, in the central nervous system. We have reported novel biological functions for Annexin A1, an effector of endogenous anti-inflammation, to produce positive actions on the adaptive immune system by reducing the threshold of T cell activation. In this study, we investigated the potential modulatory role of Annexin A1 in the development of experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 116 122 115 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 221 227 220 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33-55 </sub>
###xml 258 267 257 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 275 281 274 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33-55 </sub>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 162 165 <span type="species:ncbi:31658">CFA</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
Male control C57/BL6 and AnxA1 null mice were immunized subcutaneously with an emulsion consisting of 300 mug of MOG35-55 in PBS combined with an equal volume of CFA. Lymph node cells obtained from mice immunized with MOG33-55 for 14 days were re-stimulated in vitro with MOG33-55 (100 mug/ml) for 4 days and the Th1/Th17 cytokine profile measured by ELISA. Spinal cords were processed either to isolate the infiltrated T cells or fixed and stained with haematoxylin and eosin. Statistical analyses were performed using two-tailed, unpaired Student's t tests or ANOVA.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 104 109 104 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 398 407 398 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 437 443 437 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
Our results show a direct correlation between Annexin A1 expression and severity of EAE. Analysis of MOG35-55-induced EAE development in Annexin A1 null mice showed decreased signs of the disease compared to wild type mice. This defect was significant at the peak of the disease and accompanied by reduced infiltration of T cells in the spinal cord. Finally, analysis of the T cell recall response in vitro following stimulation with MOG35-55 showed a decrease proliferation of Annexin A1 null T cells, with a significantly reduced Th1/Th17 phenotype, compared to wild type cells.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Together these findings suggest that Annexin A1 null mice have an impaired capacity to develop EAE. Furthermore strategies aiming at reducing Annexin A1 functions or expression in T cells might represent a novel therapeutic approach for multiple sclerosis.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 753 754 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
Multiple sclerosis (MS) is chronic disabling disease caused by malfunction of the immune system. Like many other autoimmune diseases, it is initiated by an uncontrolled T cell response to autoantigens presented in the context of MHC molecules of antigen presenting cells. Several factors have been described as involved in the pathogenesis of MS including environmental, genetic and viral [1]. However, one feature is common to all these cases: the hyperesponsivity of T cells. In MS it is thought that myelin peptides presented by glial cells in the central nervous system (CNS) induce proliferation and activation of Th effector cells. These cells are in turn responsible for the development of the inflammatory reaction and consequent demyelination [2].
###end p 10
###begin p 11
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 718 719 718 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 720 721 720 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
Recent views on differentiation of naive CD4+ T cells in effector Th cells have shown that there are at least 3 different categories (Th1, Th2 and Th17) of effectors cell, a classification mainly based on the type of infection or immune reaction and the cytokine signature produced. Classically, Th1 cells are involved in the cellular-mediated immune reaction and their differentiation is induced upon infection by intracellular bacteria. On the other hand Th2 cells develop during infections with extracellular bacteria and they play a major role in humoral-mediated immune response [3]. Th17 are emerging as the major pathogenic cell lineage responsible for the development of autoimmune and inflammatory disorders [4,5].
###end p 11
###begin p 12
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 438 439 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 550 551 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 725 729 725 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 997 999 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1000 1002 1000 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 569 574 <span type="species:ncbi:9606">human</span>
###xml 875 883 <span type="species:ncbi:9606">patients</span>
Annexin A1 (AnxA1), previously known as lipocortin-1, was originally identified as a phospholipase A2 (PLA2)-inhibitory protein and second messenger of glucocorticoid pharmacological effects [6,7]. Subsequent studies have shown that this protein is also an effector of endogenous inflammatory resolution, where it acts to downregulate neutrophil trafficking and activation, promoting the removal of apoptotic cells by tissue macrophages [8]. However, we have recently demonstrated a novel function for AnxA1 on T cell activation and differentiation [8-10]. Addition of human recombinant (hr)AnxA1 to T cells stimulated with anti-CD3/CD28 increases their activation and favours differentiation into Th1 [11]; conversely, AnxA1-/- T cells display a decreased response to TCR stimulation associated with a marked Th2 phenotype [12]. Analysis of AnxA1 expression in T cells from patients suffering from rheumatoid arthritis showed higher levels of this protein compared to healthy control volunteers [11,13], providing clinical relevance to the role that AnxA1 might play in autoimmune diseases. Together these findings suggest that AnxA1 acts as a positive modulator of T cells and might facilitate the development of autoimmune diseases contributing to aberrant T cell activation.
###end p 12
###begin p 13
###xml 202 210 202 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex-vivo </italic>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
On these bases, we have investigated here the development of EAE in AnxA1 null mice monitoring macroscopic signs of disease in a temporal fashion, together with histological analysis of spinal cord and ex-vivo T cell reactivity upon restimulation with the specific antigen. The results obtained corroborate the hypothesis that blocking AnxA1 function or expression during autoimmune diseases might open new avenues for the therapeutic control of these pathologies.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Reagents
###end title 15
###begin p 16
###xml 53 59 53 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33-55 </sub>
###xml 203 230 203 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis </italic>
###xml 266 287 266 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis </italic>
###xml 203 229 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 266 286 <span type="species:ncbi:520">Bordetella pertussis</span>
The Myelin Oligodendrocyte Glycoprotein peptide (MOG)33-55 (MEVGWYRSPFSRVVHLYRNGK) was synthesized and purified by Cambridge Research Biochemicals (Billingham, UK). Complete Freund's adjuvant containing Mycobacterium tuberculosis H37a was purchased from Difco while Bordetella pertussis toxin was from Sigma-Aldrich Co (Poole, UK). Unless otherwise specified, all the other reagents were from Sigma-Aldrich Co.
###end p 16
###begin title 17
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 17
###begin p 18
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
Male AnxA1 null mice were previously described [14,15] (9-11 week old) and were backcrossed on a C57BL/6 background for >10 generations and bred at B&K animal care facilities (Hull, UK). Age and gender-matched control C57BL/6 mice were used as control for all experiments. Animals were kept under standard conditions and maintained in a 12 h/12 h light/dark cycle at 22 +/- 1degreesC in accordance with United Kingdom Home Office regulations (Animal Act 1986) and of the European Union directives.
###end p 18
###begin title 19
Induction of EAE
###end title 19
###begin p 20
###xml 97 103 95 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 178 194 175 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis </italic>
###xml 290 303 287 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pertussis </italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 143 146 <span type="species:ncbi:31658">CFA</span>
###xml 178 199 <span type="species:ncbi:419947">M. tuberculosis H37Ra</span>
###xml 290 302 <span type="species:ncbi:520">B. pertussis</span>
###xml 364 368 <span type="species:ncbi:10090">Mice</span>
Mice were immunized subcutaneously on day 0 with 300 mul of emulsion consisting of 300 mug of MOG35-55 in PBS combined with an equal volume of CFA containing 300 mug heat-killed M. tuberculosis H37Ra. The emulsion was injected in both flanks and followed by an intraperitoneal injection of B. pertussis toxin (500 ng/100 mul) in 100 mul of saline on days 0 and 2. Mice were observed daily for signs of EAE and weight loss. Diseases severity was scored on a 6-point scale: 0 = no disease; 1 = partial flaccid tail; 2 = complete flaccid tail; 3 = hind limb hypotonia; 4 = partial hind limb paralysis; 5 = complete hind limb paralysis; 6 = moribund or dead animal.
###end p 20
###begin title 21
Cell proliferation assay
###end title 21
###begin p 22
###xml 20 22 20 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5 </sup>
###xml 74 80 73 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33-55 </sub>
###xml 116 122 115 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33-55 </sub>
###xml 230 231 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Lymph node cells (105 cells/200 mul) obtained from mice immunized with MOG33-55 for 14 days were stimulated with MOG33-55 (50-100 mug/200 mul) for 48 h in 96 well plates. During the last 12 h, cultures were pulsed with 1 muCi of [3H]-thymidine (Amersham Pharmacia Biotech, Buckinghamshire, UK) and incorporated radioactivity was measured by automated scintillation counter (Packard Instrument Company, Inc., Illinois, US).
###end p 22
###begin title 23
Cytokine ELISA
###end title 23
###begin p 24
###xml 20 22 20 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6 </sup>
###xml 69 75 69 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33-55 </sub>
###xml 111 117 111 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33-55 </sub>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Lymph node cells (106 cells/ml) obtained from mice immunized with MOG33-55 for 14 days were stimulated with MOG33-55 (100 mug/ml) for 4 days. Cell supernatants were collected and analyzed for IFN-gamma, IL-2, IL-17A and TNF-alpha content using ELISA kits (eBioscience, Dorset, UK) according to manufacturer's instructions.
###end p 24
###begin title 25
Isolation of inflammatory cell from the spinal cord
###end title 25
###begin p 26
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 651 652 651 652 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were killed using CO2. The spinal cords were expelled from the spinal column with PBS by hydrostatic pressure using a syringe attached to a 21-gauge needle. Tissues were cut in small pieces and passed through cell strainer (70 nm; BD Falcon) using the plunger of a sterile 1 ml syringe. The single cell suspension was centrifuged for 10 min at 390 x g, resuspended in 20 ml of PBS containing 30% of Percoll (Sigma) and overlayed onto 10 ml of PBS containing 70% Percoll. After centrifugation at 390 x g for 20 min, the mononuclear cells were removed from the interphase, washed, and resuspended in FACS buffer (PBS containing 1% FCS and 0.02% NaN2) for further analysis.
###end p 26
###begin title 27
Flow cytometry
###end title 27
###begin p 28
###xml 575 577 559 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4 </sup>
Cell samples from Percoll-purified spinal cord tissues or Ficoll-purified lymph nodes were resuspended in FACS buffer containing CD16/CD32 FcgammaIIR blocking antibody (clone 93; eBioscience) for 30 min at 4degreesC. Thereafter, cell suspensions were labelled with the FITC-conjugated anti-CD3 (1:100; clone 145 2C11) or anti-F4/80 (1:100; clone BMT) while lymph node cells were stained with anti-CD4-FITC (1:500; clone L3T4) and anti-CD8 (1:1000; clone Ly-2) for 30 min at 4degreesC, prior to analysis by FACS calibur using CellQuest software (Becton Dickinson). At least 104 cells were analyzed per sample, and determination of positive and negative populations was performed based on the staining attained with irrelevant IgG isotypes.
###end p 28
###begin title 29
Histology
###end title 29
###begin p 30
###xml 585 591 <span type="species:ncbi:9986">rabbit</span>
###xml 595 606 <span type="species:ncbi:3704">horseradish</span>
Spinal cord tissues were dissected and fixed in 4% neutral buffered formalin for 48 hrs and then incubated with decalcifying solution containing EDTA (0.1 mM in PBS) for 14 days prior to paraffin embedding. Histological evaluation was performed on paraffin-embedded sections sampled at various time points depending on disease severity. Spinal cord sections (5 mum) were deparaffinized with xylene and stained with haematoxylin and eosin (H&E) to asses inflammation. The staining for AnxA1 was performed on frozen sections using anti-AnxA1 (dilution 1:500; Zymed, Invitrogen) and anti-rabbit Ig horseradish peroxidase (HRP)-conjugated antibodies (dilution 1:500; Dako). Double staining for AnxA1 and CD3 or F4/80 was carried out as previously described using FITC-conjugated anti-CD3 (1:100; clone 145 2C11) or anti-F4/80 (1:100; clone BMT). Sections were also counterstained with haematoxylin. In all cases, a minimum >/= 3 sections per animal were evaluated. Phase-contrast digital images were taken using the Image Pro image analysis software package.
###end p 30
###begin title 31
Statistical Analysis
###end title 31
###begin p 32
###xml 426 428 424 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n </italic>
Prism software (GraphPad software) was used to run all the tests. Statistical evaluations of cell frequency, proliferation and cytokine production were performed using two-tailed, unpaired Student's t tests. ANOVA were applied to analyze the EAE clinical grading. A p value of < 0.05 was considered to be statistically significant. P-values lower than 0.05 were considered significant. Data are presented as mean +/- S.E.M of n samples per group.
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
AnxA1 expression correlates with the severity of EAE
###end title 34
###begin p 35
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 313 318 313 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 406 412 406 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 73 76 <span type="species:ncbi:10116">rat</span>
###xml 263 268 <span type="species:ncbi:10090">mouse</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
Previous studies on the role of AnxA1 in the development of EAE in Lewis rat demonstrated a correlation between AnxA1 levels in the spinal cord content and extent of infiltrating mononuclear cells in the CNS [16]. We started off by assessing these phenomena in a mouse model of MS induced by immunization with MOG35-55. To this aim, we collected spinal cords and brains of wild type mice immunized with MOG35-55 peptide at different stages of the diseases i.e. at day 12 (score 0), day 18 (score 2) and day 20 (score 4) and performed immunohystochemistry for AnxA1 side by side with hematoxylin and eosin staining.
###end p 35
###begin p 36
###xml 19 20 19 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
As shown in Figure 1, spinal cord tissues collected during the induction phase of mice with no signs of disease showed a faint staining for AnxA1 (score 0, Fig. 1A and 1B, respectively). However, with the onset of clinical signs and the appearance of inflammatory infiltrates in the CNS, discrete patches of AnxA1 immunostaining were observed all around the meninges (score 2, Fig. 1A and 1B, respectively). As the disease progressed, an increase in number of AnxA1-positive cellular infiltrate patches was observed (score 4, Fig. 1A and 1B, respectively), suggesting that the infiltration of inflammatory cells expressing high levels of AnxA1 might be correlated with the severity of the disease.
###end p 36
###begin p 37
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AnxA1 expression correlates with the severity of EAE</bold>
###xml 90 96 90 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 172 173 172 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 247 248 247 248 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 265 266 265 266 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 100 103 <span type="species:ncbi:31658">CFA</span>
AnxA1 expression correlates with the severity of EAE. C57BL/6 mice were immunized with MOG35-55 and CFA and spinal cords removed at day 12 (score 0), day 18 (score 2) and (C) day 20 (score 4). The sections were stained with hematoxylin and eosin (A) or anti-AnxA1 (B) as described in Materials and Methods. For each staining, the right panels (20x) show a higher magnification of an area of the left panels (4x). Results representative of 3 experiments.
###end p 37
###begin p 38
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2B</xref>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2B</xref>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
To identify the cellular sources of AnxA1 immunoreactivity in the spinal cord, we performed double immunofluorescence staining of the sections with anti-AnxA1 and either anti-CD3 (marker for T cells) or anti-F4/80 (marker for macrophages). As expected, we detected a large number of infiltrated T cells and macrophages in the spinal cord sections of mice at the peak of EAE (Fig. 2A and 2B, middle panels, respectively). However, AnxA1 staining in the same sections showed a partial co-localization with both T cells and macrophages without particular preference for one or the other cell types (Fig. 2A and 2B, right panels, respectively).
###end p 38
###begin p 39
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cellular phenotype of AnxA1 expressing cells in spinal cord sections of mice with severe EAE</bold>
###xml 130 136 130 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 246 247 246 247 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 264 265 264 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 140 143 <span type="species:ncbi:31658">CFA</span>
Cellular phenotype of AnxA1 expressing cells in spinal cord sections of mice with severe EAE. C57BL/6 mice were immunized with MOG35-55 and CFA and spinal cords removed at day 20 (score 4). The sections were stained with anti-AnxA1 and anti-CD3 (A) or anti-F4/80 (B) as described in Materials and Methods. The right panels show an overlay of the two single stainings on the right. Results representative of 3 experiments.
###end p 39
###begin title 40
###xml 5 9 5 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
AnxA1-/- mice develop an impaired EAE
###end title 40
###begin p 41
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 149 153 149 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 186 192 186 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 245 258 245 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pertussis </italic>
###xml 299 303 299 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 312 316 312 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 427 431 427 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 483 487 483 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 203 206 <span type="species:ncbi:31658">CFA</span>
###xml 245 257 <span type="species:ncbi:520">B. pertussis</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
Since AnxA1 expression was upregulated at the peak of EAE, we next investigated the role of this protein on the development of EAE. AnxA1+/+and AnxA1-/- mice were immunized s.c. with MOG35-55 peptide in CFA on day 0, and then injected i.v. with B. pertussis toxin on both day 0 and day 2. Both AnxA1+/+ and AnxA1-/- mice started to develop EAE from day 12 after immunization, reaching peak disease around day 20. However, AnxA1-/- mice had reduced levels of disease compared to AnxA1+/+ (Figure 3A). Interestingly, this was evident and significant only at the later stage of the disease i.e. from day 18 to 23 and onwards.
###end p 41
###begin p 42
###xml 5 9 5 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 50 53 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AnxA1<sup>-/- </sup>mice developed less severe EAE than AnxA1<sup>+/+</sup></bold>
###xml 91 97 91 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 156 157 156 157 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 180 181 180 181 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 101 104 <span type="species:ncbi:31658">CFA</span>
AnxA1-/- mice developed less severe EAE than AnxA1+/+. C57BL/6 mice were immunized with MOG35-55 and CFA and monitored daily for signs and symptoms of EAE (A) or weight gain/loss (B) for 23 days. Results are means +/- SEM (n = 10/group). ** p < 0.01, representative of 3 experiments.
###end p 42
###begin p 43
###xml 324 328 324 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 350 354 350 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3B</xref>
###xml 425 429 425 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 438 442 438 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
Studies on animal models of EAE have demonstrated that the acute phase of the disease coincides with weight loss, probably due to anorexia and deficient fluid uptake. Weight measurement of immunized mice correlated with the severity of the clinical score and showed a reduced weight loss - from day 18 onwards - in the AnxA1-/- mice compared to AnxA1+/+ controls (Figure 3B). Further comparison of development of EAE in AnxA1+/+ and AnxA1-/- mice showed a decrease in both the mortality rate and maximum disease score, without differences in the incidence rate or disease onset (Table 1).
###end p 43
###begin p 44
###xml 26 31 26 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 52 56 52 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 65 69 65 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Clinical parameters of MOG35-55-induced EAE in AnxA1+/+ and AnxA1-/- mice (mean +/- SEM, n = 10/group)
###end p 44
###begin p 45
**p < 0.01, representative of 3 experiments
###end p 45
###begin p 46
section signEAE clinical score equal or greater than 1.
###end p 46
###begin title 47
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro </italic>
###xml 31 37 31 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 45 49 45 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
In vitro recall response to MOG35-55 in AnxA1-/- mice
###end title 47
###begin p 48
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 64 68 64 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 241 245 241 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 338 342 338 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 351 355 351 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 415 424 415 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 432 437 432 437 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 475 479 475 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 595 601 595 601 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4B</xref>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
T cells play a key role in the development of EAE [17] and AnxA1-/- T cells have an impaired capacity to respond to anti-CD3/CD28 stimulation [12]. In light of these findings, we investigated whether the decreased development of EAE in AnxA1-/- mice was associated with a lower response to antigen-stimulation. Lymph node cells from AnxA1+/+ and AnxA1-/- mice, collected 14 days after immunization, were stimulated in vitro with MOG35-55. In line with our expectations, AnxA1-/- lymph node cells showed a decreased rate of proliferation and produced lower levels of IL-2 when stimulated with MOG35-55 compared to wild-type mice (Figure 4A and 4B, respectively). Similar results were obtained with splenocytes (data not shown).
###end p 48
###begin p 49
###xml 15 20 15 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 67 69 67 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/-</sup>
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Analysis of MOG<sub>35-55</sub>-induced T cell proliferative responses in AnxA<sup>/-</sup></bold>
###xml 109 110 109 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 123 124 123 124 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 154 155 154 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 196 200 196 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 209 213 209 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 236 242 236 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 310 316 310 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 352 353 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 246 249 <span type="species:ncbi:31658">CFA</span>
Analysis of MOG35-55-induced T cell proliferative responses in AnxA/-. The graphs shown the incorporation of 3H-Thymidine (A) and the production of IL-2 (B) of lymph node cells obtained from AnxA1+/+ and AnxA1-/- mice immunized with MOG35-55 and CFA and sacrificed after 14 days. Cells were stimulated with MOG35-55 for 48 hours and pulsed with 1 muCi 3H-Thymidine for 12 hours. Cell supernatants were used to measure IL-2 production. Results are means +/- SEM (n = 4/group). * p < 0.05, ** p < 0.01, representative of 3 experiments.
###end p 49
###begin p 50
###xml 294 298 294 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5A</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5B</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5C</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5D</xref>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
These results on cell proliferation were mirrored in the number of cells recovered from the spleen and the draining lymph nodes of the immunized mice. The total cell count of Ficoll-purified spleen and lymph node mononuclear cells from the same animals, revealed a significant decrease in AnxA1-/- mice compared to controls (Figure 5A and 5B, respectively), with no measurable changes in the percentages of CD4 or CD8 positive cells (Figure 5C and 5D, respectively).
###end p 50
###begin p 51
###xml 40 45 40 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 61 65 61 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spleen and lymph node cellularity of MOG<sub>35-55</sub>-immunized AnxA1<sup>-/- </sup>mice</bold>
###xml 100 101 100 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 119 120 119 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 147 151 147 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 160 164 160 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 187 193 187 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 231 233 231 233 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </bold>
###xml 237 239 237 239 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D </bold>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 197 200 <span type="species:ncbi:31658">CFA</span>
Spleen and lymph node cellularity of MOG35-55-immunized AnxA1-/- mice. Total cell number of spleen (A) and lymph node (B) cells obtained from AnxA1+/+ and AnxA1-/- mice immunized with MOG35-55 and CFA and sacrificed after 14 days. C and D show the cytofluorimetric analysis of lymph node cells with anti-CD4 FITC and anti-CD8 PE. Results are means +/- SEM (n = 10/group). ** p < 0.01, representative of 3 experiments.
###end p 51
###begin title 52
###xml 11 16 11 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 66 70 66 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Reduced MOG35-55-specific Th1 and Th17 cytokine responses in AnxA1-/- mice
###end title 52
###begin p 53
###xml 48 54 48 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 183 187 183 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 230 236 230 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 359 363 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6A-C</xref>
###xml 473 477 465 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 507 509 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6D</xref>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Studies using draining lymph node cells from MOG35-55 immunized C57/BL6 mice showed significant changes in Th1 and Th17 cytokine production. Analysis of cytokine production from AnxA1-/- lymph node cells upon re-challenge with MOG35-55 for 96 h showed a decreased production of Th1 cytokines IFN-gamma, IL-2, and TNF-alpha compared to wild type cells (Figure 6A-C). Similarly, measurement of Th17 signature product IL-17, revealed decreased levels of this cytokine in AnxA1-/- compared to wild type (Figure 6D).
###end p 53
###begin p 54
###xml 48 53 48 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 69 73 69 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Impaired Th1 and Th17 cytokine production of MOG<sub>35-55</sub>-immunized AnxA1<sup>-/- </sup>mice</bold>
###xml 90 91 90 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 105 106 101 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 115 116 111 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 133 134 125 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 206 210 198 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 219 223 211 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 246 252 238 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 351 357 343 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 256 259 <span type="species:ncbi:31658">CFA</span>
Impaired Th1 and Th17 cytokine production of MOG35-55-immunized AnxA1-/- mice. Levels of (A) IFN-gamma, (B) IL-2, (C) TNF-alpha and (D) IL-17 in the cell supernatants of lymph node cells obtained from AnxA1+/+ and AnxA1-/- mice immunized with MOG35-55 and CFA and sacrificed after 14 days. Cells were stimulated with the indicated concentration of MOG35-55 for 4 days and the supernatants used for cytokine ELISA. Results are means +/- SEM (n = 4/group). * p < 0.05, ** p < 0.01, representative of 3 experiments.
###end p 54
###begin title 55
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
T cell infiltration in the nervous system of AnxA1-/- mice during EAE
###end title 55
###begin p 56
###xml 33 37 33 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 170 174 170 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 183 187 183 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 374 378 374 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 400 404 400 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7A</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7B</xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
The reduced signs of EAE in AnxA1-/- mice from day 18 onwards, prompted us to investigate whether there could be a neuro-pathological correlate. The spinal cords of AnxA1+/+ and AnxA1-/- treated mice, collected at day 18 or 22, were analyzed for histological evidence of inflammation. It was found that there were reduced numbers of immune cell infiltrates detected in AnxA1-/- mice compared to AnxA1+/+ animals. (Figure 7A and 7B).
###end p 56
###begin p 57
###xml 51 56 51 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 72 76 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Histological changes in spinal cord sections of MOG<sub>35-55</sub>-immunized AnxA1<sup>-/- </sup>mice</bold>
###xml 153 157 153 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 158 159 158 159 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 170 174 170 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 175 176 175 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 201 207 201 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 400 401 400 401 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 418 419 418 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 211 214 <span type="species:ncbi:31658">CFA</span>
Histological changes in spinal cord sections of MOG35-55-immunized AnxA1-/- mice. Haematoxylin-eosin staining of spinal cord sections obtained from AnxA1+/+ (A) and AnxA1-/- (B) mice immunized with MOG35-55 and CFA and sacrificed after 22 days. For each staining, the right panels (20x) show a higher magnification of an area of the left panels (4x). Consecutive sections were stained with anti-CD3 (C) or anti-F4/80 (D) as described in Materials and Methods. Pictures are representative of three separate experiments with similar results.
###end p 57
###begin p 58
###xml 55 59 55 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7C</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7D</xref>
###xml 399 403 399 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 490 494 490 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">8A</xref>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">8B</xref>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
The reduced histological signs of inflammation in AnxA1-/- mice were associated with a reduced number of CD3 and F4/80 positive cells infiltrating the CNS (Figure 7C and 7D, respectively). These qualitative analyses were confirmed by FACS measuring the percentages of CD3 and F4/80 positive leucocytes isolated from day 18 spinal cord tissues. Consistent with the immunohistochemistry results, AnxA1-/- mice had about 60 and 80% less T cells and macrophages, respectively, compared to AnxA1+/+ mice (Figure 8A and 8B, respectively).
###end p 58
###begin p 59
###xml 83 88 83 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 104 108 104 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 0 112 0 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cellular phenotype of inflammatory cells present in the spinal cord sections of MOG<sub>35-55</sub>-immunized AnxA1<sup>-/- </sup>mice</bold>
###xml 136 137 136 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 150 151 150 151 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 256 260 256 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 269 273 269 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 296 302 296 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 506 508 506 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 517 518 517 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 306 309 <span type="species:ncbi:31658">CFA</span>
###xml 387 392 <span type="species:ncbi:10090">mouse</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
Cellular phenotype of inflammatory cells present in the spinal cord sections of MOG35-55-immunized AnxA1-/- mice. FACS analysis of CD3 (A) and F4/80 (B) positive mononuclear cells recovered by Percoll gradient of spinal cord homogenates obtained from AnxA1+/+ and AnxA1-/- mice immunized with MOG35-55 and CFA and sacrificed after 14 days. The dot plots and hystograms are from a single mouse and representative of 2 experiments with n = 4 mice. The numbers in the hystograms indicate the percentage of CD3+ and F4/80+cells.
###end p 59
###begin title 60
Discussion
###end title 60
###begin p 61
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 339 343 339 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 408 416 408 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo </italic>
###xml 488 497 488 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 535 536 535 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 537 538 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 557 561 557 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 649 658 645 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 661 669 657 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo </italic>
###xml 670 672 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
Emerging evidence over the last five years has shown that AnxA1 exerts a dual function on the innate and adaptive immune systems [8,9]. In the innate immune system, endogenous AnxA1 plays a homeostatic anti-inflammatory role that controls events occurring at the very early stage of the inflammatory process. For instance, studies in AnxA1-/- mice have shown that neutrophils exhibit enhanced transmigration in vivo in the inflamed cremaster microcirculation and increased responsiveness in vitro upon challenge with PAF, fMLP or PMA [8,9]. Similarly, AnxA1-/- macrophages produce higher levels of TNF-alpha and IL-6 when challenged with LPS either in vitro or in vivo [18].
###end p 61
###begin p 62
###xml 109 113 109 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 242 251 242 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 328 332 328 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 616 621 <span type="species:ncbi:9606">human</span>
Investigation on the role of AnxA1 in the adaptive immune system provided us with an opposite scenario. AnxA1-/- T cells showed an impaired capacity to proliferate upon anti-CD3/CD28 stimulation and a skewed Th2 phenotype when differentiated in vitro [12]. Consistent with this, when we investigated the immune response of AnxA1-/- mice in a model of allergic peritonitis, we observed an increased recruitment of eosinophils in the cavity upon challenge with the ovalbumin [12]. Most interestingly, we also found that AnxA1 plays an unpredicted proinflammatory role in chronic autoimmune diseases. Administration of human recombinant AnxA1 during the immunization phase of the collagen-induced arthritis model exacerbates signs and symptoms of diseases [11].
###end p 62
###begin p 63
###xml 322 326 322 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
These results, together with the investigations on the innate immune system, suggest different effects of AnxA1 in inflammatory diseases depending on the relative contribution of the innate and adaptive arms of the immune systems. With this idea in mind, we approached this study knowing that the phenotype of EAE in AnxA1+/+ mice could not readily be predicted.
###end p 63
###begin p 64
###xml 3 8 3 8 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 444 449 <span type="species:ncbi:10090">mouse</span>
MOG35-55-induced EAE is a model for autoimmune demyelination of the central nervous system and it has been widely used to investigate pathogenic mechanisms responsible for the development of MS. Myelin-reactive T cells are considered an immunological hallmark of both EAE and MS and thought to be the driving force for the recruitment of inflammatory cells in the CNS. These recruited cells include mainly macrophages especially in the C57BL/6 mouse strains.
###end p 64
###begin p 65
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 373 377 373 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
Our results on the development of EAE in the AnxA1+/+ mice show a decreased capacity to fully develop signs of disease. This was particularly significant at the later stage i.e. when the mice start to show signs of full paralysis. Hystological analysis of the spinal cord supported these results and showed a reduced level of T cell and macrophage infiltration in the AnxA1-/- mice compared to wild type controls.
###end p 65
###begin p 66
###xml 68 72 68 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 259 263 259 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 289 298 289 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 334 339 334 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 455 459 455 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 508 510 508 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
We hypothesized that the reduction of clinical signs of EAE in AnxA1-/- mice might be due to defect in the activation and expansion of encephalitogenic T cells. The results confirmed our expectation and showed a reduced number of cells in lymph nodes of AnxA1-/- mice as well as a reduced in vitro recall proliferative response to MOG35-55. In agreement with these data, when we measured the total number of infiltrated T cells in the spinal cord of AnxA1-/- mice, a significant decrease in the number of CD3+ cells was observed. Collectively these data indicate important support properties of endogenous of AnxA1 in modulating T cell activation in this model.
###end p 66
###begin p 67
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 112 116 112 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 203 212 203 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 312 321 312 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 361 366 361 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 579 583 571 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 617 621 609 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 653 659 645 651 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 810 812 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 813 815 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
Several explanations can be provided for the AnxA1-/- mice phenotype. Studies from our lab have shown that AnxA1-/- T cells acquire a marked Th2 - but reduced Th1 and Th17 -phenotype when differentiated in vitro under optimal Th1, Th2 or Th17 skewing conditions [19]. Here we confirm these results and show that in vitro stimulation of lymph node cells from MOG35-55immunized mice with the same antigen produced reduced amounts of Th1 (TNF-alpha, IL-2 and IFNgamma) and Th17 (IL-17) cytokines. Analysis of Th2 cytokine IL-4 and IL-5 showed almost double basal production in AnxA1-/- lymph node cells compared to AnxA1+/+ but no further increase upon MOG35-55 stimulation (data not shown). This might be due to the fact that fully differentiated Th2 cells appear during the late remission stage of the disease [20,21], while our analyses have been carried out soon after the onset of the disease.
###end p 67
###begin p 68
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 382 384 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 454 456 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 457 459 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 513 515 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 529 531 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 548 550 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 551 553 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 677 679 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 824 826 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 998 1000 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 372 380 <span type="species:ncbi:9606">patients</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
Studies on Th cell differentiation during the development of EAE have shown the involvement of Th1 and Th17 cells during the first phase. However, controversial results present in the literature on this aspect do not provide a conclusive answer on what would be the exact role(s) of Th1 or Th17 [22]. Indeed, administration of IFN-gamma exacerbates signs of disease in MS patients [23] and adoptive transfer of Th1 cells effectively induces EAE in mice [24,25]. On the other hand, mice deficient for IL-12 (p35) [26], IFN-gamma [27] and TNF-alpha [28,29] showed no overt impairment in the development of EAE. Similarly, multiple sclerosis lesions contain high levels of IL-17 [30] and, in animal models, adoptive transfer of Th17 cells induce a more severe EAE compared to the lesions produced by the transfer of Th1 cells [31]. This conclusion, again, is in contrast with investigations where overexpression or ablation of IL-17A, specifically in T cells, had no effect on the development of EAE [32].
###end p 68
###begin p 69
###xml 82 86 82 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 366 370 366 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 524 529 524 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 829 835 829 835 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 850 854 850 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 1029 1033 1029 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
###xml 1033 1037 <span type="species:ncbi:10090">mice</span>
Our results showing an impaired production of both Th1 and Th17 cytokines in AnxA1-/- deficient T cells suggest that the downstream events elicited by this protein might be shared by both the Th1 and Th17 pathways. However, further studies are needed to verify this hypothesis. One possibility might be that the decreased strength of TCR signalling observed in AnxA1-/- T cells contributes to the inhibition of Th1 and Th17 development [17,33]. Most interestingly, an elegant study by Juedes et al. has shown that in the MOG35-55-induced EAE in C57/BL6 mice the early infiltration of Th1 cells is the key to sequential cascade of events i.e. activation of microglia, induction of VCAM and ICAM and finally traffic of mononuclear cells across the endothelium. Our phenotypic characterization of the cellular infiltrates of the MOG35-55 immunized AnxA1-/- confirmed these results and showed a reduced number of macrophages compared to wild type mice reinforcing the hypothesis that the reduced development of Th1 cells in the AnxA1-/- mice might be responsible for this effect.
###end p 69
###begin p 70
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 136 139 <span type="species:ncbi:10116">rat</span>
Previous studies on the effects of a truncated version of human recombinant AnxA1 (amino acid 1-188) on the development of EAE in Lewis rat have shown a significant inhibitory effects on mild but not severe EAE [34]. These apparently contrasting results can be explained by the fact that in this study the authors tested the well-known antinflammatory action of exogenously administered AnxA1 by administering the recombinat protein intracerebroventricularly at the onset and throughout the peak of the disease. Interestingly, the same study showed that intracerebroventricular administration of a neutralizing antibody against AnxA1 did not modify the development of EAE [34]. Together these results support our findings showing a prominent role of endogenous AnxA1 in influencing the activation of the immune system that precedes the development of EAE.
###end p 70
###begin p 71
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 272 278 272 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55 </sub>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 935 943 <span type="species:ncbi:9606">patients</span>
Previous studies on role of AnxA1 in the development of EAE demonstrated that the cerebellum and spinal cord content of AnxA1 correlated with appearance of infiltrating lymphocytes and macrophages in the CNS [16,34,35]. We confirmed these results also in this model of MOG35-55 induced EAE. Immunohystochemistry for AnxA1 in spinal cord of wild type mice showed a faint staining during the induction phase of the disease. However, with the onset of clinical signs and the appearance of inflammatory infiltrates in the CNS, a marked increase in AnxA1 immunostaining was observed. This was maximal at the peak of the symptoms and suggested that the infiltration of inflammatory cells expressing high levels of AnxA1 might be correlated with the severity of the disease and the consequent tissue damage. In agreement with this hypothesis, previous studies have shown an increase in AnxA1 content in post-mortem CNS tissue samples from MS patients, in particular in the diseased white matter as well as in multiple sclerosis plaque tissue [36].
###end p 71
###begin title 72
Conclusion
###end title 72
###begin p 73
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
In conclusion, this study presents novel evidences of pivotal roles for AnxA1 in a mouse model of multiple sclerosis. Based on the data produced, we propose that AnxA1 deficient T cells might be responsible for the failure to recruit significant number of inflammatory cells into CNS. More analysis is needed to characterize the phenotype of the T cells infiltrating into the CNS in order to further understand the molecular mechanisms by which AnxA1 influences the development of EAE. Nevertheless, our results clearly suggest that the level of expression of this protein in T cells may have a causal function. Future studies on the identification and generation of neutralizing antibodies against AnxA1, currently under development, will provide us the opportunity to validate novel therapeutic approaches for the treatment of multiple sclerosis that target AnxA1 expression or function.
###end p 73
###begin title 74
Competing interests
###end title 74
###begin p 75
The authors declare that they have no competing interests.
###end p 75
###begin title 76
Authors' contributions
###end title 76
###begin p 77
Design of studies NP, FDA. Experimental induction of EAE, NP and preparation of tissues NP, AJI, FM, EGW, FDA. Writing/reviewing of manuscript NP, MP, RJF, FDA. All authors have read and approved the final manuscript.
###end p 77
###begin title 78
Acknowledgements
###end title 78
###begin p 79
The authors wish to thank Prof. David Baker and Dr. Chris Bolton for help, suggestions and critical review of the Manuscript (Neuroimmunology Unit, Neuroscience Centre, Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK). This study was funded by an Innovative Award of the Multiple Sclerosis Society (reference number 860/07). N.P. is supported by an Arthritis Research Campaign UK PhD Studentship (16125).
###end p 79
###begin article-title 80
From genes to function: the next challenge to understanding multiple sclerosis
###end article-title 80
###begin article-title 81
Autoimmune T cell responses in the central nervous system
###end article-title 81
###begin article-title 82
The lineage decisions of helper T cells
###end article-title 82
###begin article-title 83
Regulation and function of proinflammatory TH17 cells
###end article-title 83
###begin article-title 84
Th17: an effector CD4 T cell lineage with regulatory T cell ties
###end article-title 84
###begin article-title 85
Annexin 1: more than an anti-phospholipase protein
###end article-title 85
###begin article-title 86
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids
###end article-title 86
###begin article-title 87
Annexin A1 and glucocorticoids as effectors of the resolution of inflammation
###end article-title 87
###begin article-title 88
Annexin-A1: a pivotal regulator of the innate and adaptive immune systems
###end article-title 88
###begin article-title 89
On the adaptive nature of Annexin-A1
###end article-title 89
###begin article-title 90
Annexin-1 modulates T-cell activation and differentiation
###end article-title 90
###begin article-title 91
Impaired t cell activation and increased T helper 2 lineage commitment in Annexin-1 deficient T cells
###end article-title 91
###begin article-title 92
Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cells
###end article-title 92
###begin article-title 93
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse
###end article-title 93
###begin article-title 94
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
The annexin-1 knockout mouse: what it tells us about the inflammatory response
###end article-title 94
###begin article-title 95
###xml 79 83 <span type="species:ncbi:10116">rats</span>
Lipocortin 1 (annexin 1) immunoreactivity in the cervical spinal cord of Lewis rats with acute experimental allergic encephalomyelitis
###end article-title 95
###begin article-title 96
T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis
###end article-title 96
###begin article-title 97
###xml 74 80 <span type="species:ncbi:10090">murine</span>
Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation
###end article-title 97
###begin article-title 98
Impaired T cell activation and increased Th2 lineage commitment in Annexin-1-deficient T cells
###end article-title 98
###begin article-title 99
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery
###end article-title 99
###begin article-title 100
Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain
###end article-title 100
###begin article-title 101
A rush to judgment on Th17
###end article-title 101
###begin article-title 102
###xml 39 47 <span type="species:ncbi:9606">patients</span>
Exacerbations of multiple sclerosis in patients treated with gamma interferon
###end article-title 102
###begin article-title 103
###xml 53 57 <span type="species:ncbi:10090">mice</span>
IL-12 unmasks latent autoimmune disease in resistant mice
###end article-title 103
###begin article-title 104
Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma
###end article-title 104
###begin article-title 105
###xml 19 23 <span type="species:ncbi:10090">mice</span>
IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination
###end article-title 105
###begin article-title 106
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)
###end article-title 106
###begin article-title 107
TNF and receptors in organ-specific autoimmune disease: multi-layered functioning mirrored in animal models
###end article-title 107
###begin article-title 108
Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination
###end article-title 108
###begin article-title 109
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
###end article-title 109
###begin article-title 110
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
###end article-title 110
###begin article-title 111
###xml 80 84 <span type="species:ncbi:10090">mice</span>
IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice
###end article-title 111
###begin article-title 112
The value of animal models for drug development in multiple sclerosis
###end article-title 112
###begin article-title 113
###xml 78 81 <span type="species:ncbi:10116">rat</span>
Effect of annexin-1 on experimental autoimmune encephalomyelitis (EAE) in the rat
###end article-title 113
###begin article-title 114
###xml 85 89 <span type="species:ncbi:10116">rats</span>
The detection of lipocortins 1, 2 and 5 in central nervous system tissues from Lewis rats with acute experimental allergic encephalomyelitis
###end article-title 114
###begin article-title 115
Lipocortins (annexins) 1, 2, 4 and 5 are increased in the central nervous system in multiple sclerosis
###end article-title 115

